Stock Research for AKZOF

AKZOF

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

AKZOF Stock Chart & Research Data

The AKZOF chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the AKZOF chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


AKZOF Due diligence Resources & Stock Charts

The AKZOF stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View AKZOF Detailed Price Forecast - CNN Money CNN View AKZOF Detailed Summary - Google Finance
Yahoo View AKZOF Detailed Summary - Yahoo! Finance Zacks View AKZOF Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View AKZOF Trends & Analysis - Trade-Ideas Barrons View AKZOF Major Holders - Barrons
NASDAQ View AKZOF Call Transcripts - NASDAQ Seeking View AKZOF Breaking News & Analysis - Seeking Alpha
Spotlight View AKZOF Annual Report - CompanySpotlight.com OTC Report View AKZOF OTC Short Report - OTCShortReport.com
TradeKing View AKZOF Fundamentals - TradeKing Charts View AKZOF SEC Filings - Bar Chart
WSJ View Historical Prices for AKZOF - The WSJ Morningstar View Performance/Total Return for AKZOF - Morningstar
MarketWatch View the Analyst Estimates for AKZOF - MarketWatch CNBC View the Earnings History for AKZOF - CNBC
StockMarketWatch View the AKZOF Earnings - StockMarketWatch MacroAxis View AKZOF Buy or Sell Recommendations - MacroAxis
Bullish View the AKZOF Bullish Patterns - American Bulls Short Pains View AKZOF Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View AKZOF Stock Mentions - StockTwits PennyStocks View AKZOF Stock Mentions - PennyStockTweets
Twitter View AKZOF Stock Mentions - Twitter Invest Hub View AKZOF Investment Forum News - Investor Hub
Yahoo View AKZOF Stock Mentions - Yahoo! Message Board Seeking Alpha View AKZOF Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for AKZOF - SECform4.com Insider Cow View Insider Transactions for AKZOF - Insider Cow
CNBC View AKZOF Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for AKZOF - OTC Markets
Yahoo View Insider Transactions for AKZOF - Yahoo! Finance NASDAQ View Institutional Holdings for AKZOF - NASDAQ


Stock Charts

FinViz View AKZOF Stock Insight & Charts - FinViz.com StockCharts View AKZOF Investment Charts - StockCharts.com
BarChart View AKZOF Stock Overview & Charts - BarChart Trading View View AKZOF User Generated Charts - Trading View




Latest Financial News for AKZOF


Wall Street Wins Its High Stakes Bet on Akzo Nobel Buyout
Posted on Friday September 21, 2018

The decision of a group of Wall Street banks to underwrite the buyout financing for Akzo Nobel NV chemicals unit paid off, with the 6.4 billion-euro ($7.5 billion) debt sale wrapping up this week after attracting overwhelming demand. Barclays Plc, HSBC Holdings Plc and JPMorgan Chase & Co. earlier this year committed to fund Carlyle Group LP’s $12.5 billion acquisition of the Akzo Nobel business at a time when the leveraged finance market was burning hot.


Akzo Nobel loans break for trading
Posted on Thursday September 20, 2018

The US$6.44bn in term loans backing Carlyle Group and Singaporean wealth fund GIC’s acquisition of Akzo Nobel’s chemicals business allocated and broke for trading on Thursday. The US$4.34bn seven-year term loan B broke at 100.375-100.75 on Thursday, while the US$2.1bn-equivalent euro-denominated facility broke at 100.5-101. Pricing on the US$4.34bn term loan B was finalized at 325bp plus Libor, tightened from earlier guidance of 350bp-375bp range and 400bp-425bp range at launch.


Envision’s $5.05 billion loan marks jumbo buyout trio
Posted on Thursday September 20, 2018

The $5.05 billion (3.81 billion pounds) term loan for Envision Healthcare is the third massive leveraged loan to hit the market since September and also looks set to benefit from huge institutional demand which has already seen multibillion buyout loans for Thomson Reuters’ F&R business, Refinitiv, and Akzo Nobel’s Specialty Chemicals business successfully placed. Envision’s loan will bring the total of jumbo loans syndicated since early September to US$20.7bn, in addition to the US$9.25bn loan for Refinitiv and Akzo Nobel’s US$6.44bn loan. Although the commitment deadline for Envision’s loan is October 1, the deal is already fully subscribed and is expected to tighten in line with the two previous jumbo deals, bankers said.


Biggest Buyout Financings Steamroll Over Investor Safeguards
Posted on Wednesday September 12, 2018

The year’s biggest buyout financing, backing the $20 billion acquisition of Thomson Reuters Corp.’s spinoff, Refinitiv, is challenging some hard-won investor protections. The deals are bucking a trend of investor pushback in Europe this year. In recent months power has shifted back in favor of high-yield investors, particularly in Europe, where at least 11 deals have either been delayed or withdrawn so far this year, and swathes of transactions that priced were heavily amended.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.